Vimarsana
Biggest News Aggregation in the World

Page 3 - Marie Utter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marie Utter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marie Utter Today - Breaking & Trending Today

PTC Therapeutics (NASDAQ:PTCT) Given New $64.00 Price Target at JPMorgan Chase & Co. - Vimarsana News

PTC Therapeutics (NASDAQ:PTCT) Given New $64.00 Price Target at JPMorgan Chase & Co.

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its price target hoisted by JPMorgan Chase & Co. from $57.00 to $64.00 in a research note published on Monday morning, The Fly reports. A number of other equities analysts have also commented on PTCT. Credit Suisse Group boosted their price target on shares of PTC Therapeutics from […]

FY2026 EPS Estimates for PTC Therapeutics, Inc. Reduced by Analyst (NASDAQ:PTCT) - Vimarsana News

FY2026 EPS Estimates for PTC Therapeutics, Inc. Reduced by Analyst (NASDAQ:PTCT)

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) – Research analysts at Jefferies Financial Group cut their FY2026 earnings per share (EPS) estimates for PTC Therapeutics in a research note issued on Thursday, April 27th. Jefferies Financial Group analyst K. Shi now expects that the biopharmaceutical company will post earnings of $1.99 per share for the […]

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $51.00 at Credit Suisse Group - Vimarsana News

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $51.00 at Credit Suisse Group

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price increased by Credit Suisse Group from $48.00 to $51.00 in a research report released on Friday morning, The Fly reports. Other research analysts have also recently issued reports about the company. SVB Leerink reissued a market perform rating and issued a $48.00 target price on […]

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $51.00 at Credit Suisse Group - Vimarsana News

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $51.00 at Credit Suisse Group

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price upped by stock analysts at Credit Suisse Group from $48.00 to $51.00 in a report issued on Friday, The Fly reports. Credit Suisse Group’s target price would suggest a potential downside of 7.51% from the company’s previous close. Other analysts have also recently issued research […]

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $67.00 - Vimarsana News

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $67.00

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its price objective raised by Citigroup from $61.00 to $67.00 in a research note issued to investors on Friday morning, The Fly reports. Other equities analysts also recently issued research reports about the stock. SVB Leerink reaffirmed a market perform rating and set a $48.00 price target on […]